In mammary carcinoma, exon 20 mutations in PIK3CA were described to correlate with TP53 mutations in one study [136], whereas mutant TP53 preferentially associates with triple negative BC, and PI3KCA mutations predominantly associate with ER + /PR+ BC in another [137]. This evidence concerns the gene PIK3CA and breast carcinoma.